[1] [2] Menstrual irregularities are not listed as a recognised adverse reaction in the Summary of Product Characteristics (SmPC) approved by the Medicines and Healthcare products Regulatory Agency (MHRA), though some women have reported changes to their menstrual cycle while taking this medication
In more recent studies comparing long acting GLP-1RAs, once weekly semaglutide demonstrated superior glycemic efficacy and weight loss compared to exenatide extended release (SUSTAIN-3) or dulaglutide (SUSTAIN-7) (40, 41) Head-to-Head Studies OF DPP-4 Inhibitors vs
Within the first few weeks, she noticed that her cravings had diminished significantly, making it easier for her to stick to her dietary goals
Serum potassium should be closely observed the first 48 hours and potassium should be administered if necessary
Shehadeh N, Zuckerman-Levin N, Said W, Zolotov S, Elemy A